Schedule 13G ownership disclosure

Silence Therapeutics plc

Security class unavailable · CUSIP: G8128Y157

Event date: 2022-08-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-22-010427
Form type
SC 13G
Filer
Silence Therapeutics plc
CIK
CIK 1479615
Filed
Aug 19, 2022
Reporting period
Aug 12, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub